Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
5/17/2013 9:24:17 AM
More...
|
Hyperion Therapeutics Announces First Quarter 2013 Operating Results
5/10/2013 9:29:52 AM
More...
|
Hyperion Therapeutics Announces Pricing of Follow-On Offering
3/8/2013 10:17:18 AM
More...
|
FDA Approves Hyperion Therapeutics Drug for Urea Cycle Disorders
2/4/2013 7:05:25 AM
More...
|
Hyperion Therapeutics Notified That FDA Will Not Meet the PDUFA Action Date for Ravicti™
1/16/2013 9:13:19 AM
More...
|
Hyperion Therapeutics Release: HALT-HE Study Underscores Role of Ammonia in Hepatic Encephalopathy
11/12/2012 7:38:59 AM
More...
|
Hyperion Therapeutics Announces Third Quarter 2012 Operating Results
11/8/2012 9:46:50 AM
More...
|
Hyperion Therapeutics to Present at Upcoming Investor Conferences in November
11/6/2012 9:41:32 AM
More...
|
Hyperion Therapeutics to Host/Webcast Analyst and Investor Briefing at American Association for Study of Liver Diseases
10/18/2012 9:15:45 AM
More...
|
Hyperion Therapeutics to Report Results of HALT-HE Study at American Association for Study of Liver Diseases Plenary Session
10/3/2012 9:52:00 AM
More...
|
|